• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSS1000004 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Import Drug Application 2010-06-21 Baxter SA;Baxter AG Certificate Issued 2012-05-10 view
JYSB1900083 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2019-04-24 Wyeth Farma SA;Pfizer Ltd Certificate Issued 2019-10-30 view
JYSB2100026 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-01-22 Pfizer Europe Ma Eeig;Wyeth Farma SA In Review 2021-01-21 view
JXSL1600038 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Import Drug Application 2016-07-11 Bayer Pharma AG Certificate Issued 2018-07-27 view
JYSB0800073 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2008-06-28 Bayer Healthcare LLC Certificate Issued 2009-07-31 view
JYSB1800114 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-05-17 Baxter AG;Baxalta Manufacturing Sàrl Filed 2018-05-30 view
JYSB2000404 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2020-08-21 Pfizer Europe Ma Eeig;Wyeth Farma SA Filed 2020-09-01 view
JYSB1500116 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2015-04-24 Wyeth Farma SA;Wyeth Pharmaceuticals Inc Certificate Issued 2015-10-29 view
JYSB2200092 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-06-09 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JYSB1700078 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2017-05-03 Bayer Healthcare LLC Certificate Issued 2018-06-15 view
JYSZ2200049 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2022-09-14 Bayer Healthcare LLC;Bayer Healthcare Company Ltd view
JYSB2400158 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-07-16 Pfizer Europe Ma Eeig;Wyeth Farma SA view
CYSB2200011 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2022-01-10 SinoCelltech Ltd view
JYSB1800179 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-08-17 Wyeth Farma SA;Pfizer Ltd Filed 2018-08-23 view
JYSB2000558 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2020-11-04 Bayer Healthcare LLC Filed 2020-11-17 view
JYSB1500133 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2015-05-19 Baxter AG;Baxter Bioscience Manufacturing Sarl Certificate Issued 2017-03-27 view
JYSB2200094 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-06-09 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JYSB1800048 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-03-23 Bayer Healthcare LLC Certificate Issued 2018-07-27 view
JYSB1400239 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2014-12-09 Wyeth Farma SA;Wyeth Pharmaceuticals Inc Certificate Issued 2015-06-19 view
JYSB2200063 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-04-08 Novo Nordisk A/S view